Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway

癌症干细胞 癌症研究 车站3 干细胞 肝癌 生物 信号转导 医学 细胞生物学 肝细胞癌
作者
Xiaoli Wang,Yunfeng Bai,Yan Xue,Jin Li,BingXue Lin,Linzhi Dai,Cheng Xu,Hua Li,Dong Liu,Yang Tai,Tao Zhang
出处
期刊:Anti-Cancer Drugs [Ovid Technologies (Wolters Kluwer)]
卷期号:32 (5): 548-557 被引量:9
标识
DOI:10.1097/cad.0000000000001062
摘要

Cancer stem cells (CSCs), a crucial cancer cell subpopulation, possess stemness phenotypic characteristics. Cucurbitacin B (CuB), a tetracyclic triterpenoid isolated from Cucurbitaceae , exerts widely pharmacological activities in many diseases. The aim of this study was to enrich, identify liver CSCs and investigate antitumor effects of CuB as well as explore the underlying molecular mechanisms in these liver CSCs. HepG2 cell lines were used for the enrichment of liver CSCs by serum-free medium culture and magnetic-activated cell sorting. The CSC characteristics were analyzed by immunofluorescent staining, sphere-forming, western blot and xenograft tumorigenicity assay. CuB’ antitumor effects and underlying molecular mechanism were measured by cell counting kit-8, colony formation, sphere-forming, cell cycle, xenograft and western blot assay. Our results showed that we could enrich 97.29% CD133+ HepG2 cells, which possessed CSC characteristics including re-renewal capacity, proliferative ability, sorafenib resistance, overexpressed stemness-related molecules and enhanced tumorigenic potential. Furthermore, we also found that CuB inhibited cell viability, sphere formation, colony formation and arrested cell cycle at G2/M phase as well as sensitized CD133+ HepG2 cells to sorafenib in vitro and in vivo. Western blot assay indicated that CuB inhibited expression levels of cyclin B1, CDK1, CD133, p-JAK2 and p-STAT3. In conclusion, our findings indicated that CuB could exhibit antitumor effects on CD133+ HepG2 CSCs by inhibiting the Janus kinase 2/signal transducers and activators of transcription-3 signaling pathway, expanding basic and preclinical investigations on liver CSCs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kidd瑞完成签到,获得积分10
2秒前
gg完成签到,获得积分10
4秒前
suiwuya完成签到,获得积分10
4秒前
18062677029完成签到 ,获得积分10
4秒前
LISHO完成签到 ,获得积分10
4秒前
dbdxyty完成签到,获得积分10
5秒前
不停疯狂完成签到 ,获得积分10
7秒前
MZ完成签到,获得积分10
14秒前
傻傻的盛男完成签到,获得积分10
15秒前
17秒前
mengzhonghunli完成签到,获得积分20
18秒前
单纯的寄云完成签到 ,获得积分10
21秒前
和谐的醉山完成签到,获得积分10
22秒前
田様应助慕航采纳,获得30
24秒前
29秒前
Shabby0-0完成签到,获得积分10
30秒前
老衲完成签到,获得积分10
30秒前
yan完成签到 ,获得积分10
31秒前
义气绿柳发布了新的文献求助10
32秒前
雅2018完成签到 ,获得积分10
34秒前
35秒前
慕航完成签到,获得积分10
35秒前
陈少华完成签到 ,获得积分10
36秒前
慕航发布了新的文献求助30
38秒前
大模型应助Denmark采纳,获得30
40秒前
星希完成签到 ,获得积分10
45秒前
圭义完成签到 ,获得积分10
47秒前
耍酷雁风完成签到,获得积分10
50秒前
00完成签到 ,获得积分10
54秒前
wanci应助LJJ采纳,获得10
54秒前
Rebeccaiscute完成签到 ,获得积分10
56秒前
JUGG完成签到,获得积分10
58秒前
cmwang完成签到,获得积分10
1分钟前
全问筠完成签到,获得积分10
1分钟前
cmwang发布了新的文献求助20
1分钟前
1分钟前
孔刚完成签到 ,获得积分10
1分钟前
1分钟前
rid4iuclous2完成签到,获得积分10
1分钟前
Denmark发布了新的文献求助30
1分钟前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2546270
求助须知:如何正确求助?哪些是违规求助? 2175702
关于积分的说明 5600512
捐赠科研通 1896445
什么是DOI,文献DOI怎么找? 946285
版权声明 565379
科研通“疑难数据库(出版商)”最低求助积分说明 503557